What happens to your vagina over the years?

The female reproductive tract — including the vagina — undergoes continuous, predictable changes across the lifespan under the influence of genetics, hormonal milieu, reproductive events and aging. Understanding those changes helps clinicians anticipate common symptoms, choose appropriate preventive care, and offer effective treatments for bothersome conditions. This article summarizes the major anatomic and physiologic changes that occur from infancy through older age, outlines common clinical issues, and presents evidence-based strategies for maintaining vulvovaginal health. (Sources: ACOG, NIH, Mayo Clinic, Cleveland Clinic)

Basic anatomy and physiology (brief overview)

The term “vagina” refers to the muscular canal extending from the vulvar introitus to the cervix. Surrounding structures include the vulva (external genital tissues such as the labia and clitoris) and the pelvic floor muscles that support these organs. The vaginal mucosa consists of stratified squamous epithelium that is responsive to sex steroid hormones, particularly estrogen. Vaginal secretions and the resident microbiome (dominated in reproductive years by lactobacilli) maintain an acidic pH, which provides protection against pathogens. (ACOG; NIH)

Hormones — primarily estrogens, but also progesterone and androgens — influence vaginal epithelial thickness, vascularization, lubrication, and the composition of vaginal glycogen that supports lactobacilli. Life stages that alter hormone exposure (infancy, puberty, pregnancy, contraceptive use, perimenopause, menopause) lead to corresponding changes in the vaginal tissues and environment. (Mayo Clinic; NIH)

Childhood and infancy

  • Neonatal period: During the first weeks of life, maternal estrogens that crossed the placenta may cause transient swelling of the external genitalia, leukorrhea (vaginal discharge), and a mucous plug. These effects usually resolve within a few weeks as maternal hormones clear from the infant’s circulation. (ACOG; Mayo Clinic)
  • Prepubertal years: After the neonatal effects dissipate, the vulvovaginal tissues are relatively thin, and the vaginal pH is closer to neutral. The low estrogen state renders the mucosa less keratinized and more susceptible to local irritants and infections. Common clinical issues include vulvovaginitis due to non-specific irritation (bubble baths, foreign bodies) and, less commonly, certain infections. Attention to gentle hygiene and avoiding irritants is recommended. (Mayo Clinic; NIH)

Puberty (approximately ages 8–15)

  • Hormonal activation: With the onset of puberty, ovarian production of estrogens increases. Estrogen stimulates thickening of the vaginal epithelium, maturation of the mucosal layers, and increased secretions. The microbiome shifts toward lactobacillus predominance, which lowers vaginal pH to the acidic range (typically ~3.5–4.5 in reproductive-age women) and helps protect against pathogens. (ACOG; NIH)
  • Secondary sexual characteristics: pubic hair develops, and the labia and clitoral tissues assume adult-like morphology under hormonal influence. Menarche (first menstrual period) typically occurs in mid- to late-adolescence and signifies further maturation of the reproductive axis. (ACOG)
  • Clinical implications: Adolescents may experience irregular bleeding during the first few years after menarche due to anovulatory cycles. Counseling focused on hygiene, contraception, STI prevention, and healthy behaviors is important during this period. (Mayo Clinic; ACOG)

Reproductive years (20s–30s)

  • Stable, estrogenized environment: In healthy reproductive-age women, cyclic ovarian hormone production maintains a thick, well-vascularized vaginal epithelium and robust mucosal defenses. The vaginal vault remains lubricated through transudation (fluid passage from the blood vessels into the vaginal canal) and glandular secretions; cooperative action of the epithelium and microbiome helps preserve low pH. (Mayo Clinic; NIH)
  • Variability with contraception and infections: Exogenous hormones (combined oral contraceptives, progestin-only methods, implants, IUDs) can influence bleeding patterns, cervical mucus, and subjective vaginal dryness in some women. Episodes of bacterial vaginosis, yeast infections, or sexually transmitted infections (STIs) can alter secretions, odor, and pH. Regular gynecologic care, STI screening as indicated, and vaccination (e.g., human papillomavirus) are important preventive measures. (ACOG; CDC; Mayo Clinic)
  • Pregnancy-related changes: Pregnancy induces marked vascular and glandular changes in the reproductive tract. Increased blood flow produces increased vaginal discharge (normal leukorrhea). The mucosa may appear more edematous and friable, and the risk of certain infections can change. Labor and childbirth (see below) influence long-term pelvic floor function. (ACOG; Cleveland Clinic)

Effects of childbirth and the pelvic floor

  • Vaginal delivery: Vaginal childbirth places stretching and compressive forces on the vaginal tissues, perineum and pelvic floor muscles. Tearing or an episiotomy can alter vulvar and perineal anatomy. The pelvic floor muscles may be stretched or injured, and nerves can be affected. These changes can lead to short- and long-term differences in vaginal elasticity, sensation, and pelvic support. (ACOG; Cleveland Clinic)
  • Pelvic floor dysfunction: Weakness or injury to the pelvic floor can present as pelvic organ prolapse (descent of the uterus, bladder or rectum into or through the vaginal canal), urinary or fecal incontinence, or pelvic pressure. The incidence of symptomatic pelvic floor disorders increases with parity, especially after instrumental deliveries, large babies, prolonged second stage of labor, and older maternal age at delivery. Pelvic floor muscle training (supervised physical therapy) reduces the risk and severity of many of these conditions and is recommended in appropriate patients. (Cleveland Clinic; ACOG; NIH)
  • Long-term tissue remodeling: Over months to years following childbirth, many tissues regain tone through rehabilitation and natural healing, but some women experience persistent changes in vaginal width, elasticity and supportive structures. Individual outcomes vary widely. (ACOG)

The 40s and perimenopause

  • Hormonal fluctuations: Perimenopause — the transition to menopause — is characterized by irregular ovarian function and fluctuating estrogen and progesterone levels. These hormonal changes manifest as menstrual irregularities, vasomotor symptoms, and changes in vulvovaginal tissues. (Mayo Clinic; ACOG)
  • Vaginal symptoms: As estrogen levels decline intermittently, some women experience vaginal dryness, decreased lubrication, and increased susceptibility to irritation or infections. Vaginal pH may begin to rise slightly as lactobacillus dominance is reduced. Symptoms can be intermittent and often progress over several years. (NIH; ACOG)
  • Clinical care: During this period, assessment of bleeding patterns, contraceptive needs, and evaluation of vaginal symptoms is important. Management strategies may include lifestyle measures, non-hormonal lubricants and moisturizers, and discussion of hormone therapy when systemic symptoms or genitourinary symptoms significantly impair quality of life. (Mayo Clinic; ACOG)

Menopause and postmenopause

  • Estrogen depletion and genitourinary syndrome of menopause (GSM): Menopause — defined as 12 consecutive months without menses — leads to sustained hypoestrogenism. The urogenital tissues (vagina, vulva, urethra and bladder) respond by becoming thinner, less elastic, less vascular, and less lubricated. These changes collectively are termed the genitourinary syndrome of menopause (GSM) and can include dryness, irritation, burning, and discomfort; urinary urgency and recurrent urinary tract infections are more common. (ACOG; NIH; Mayo Clinic)
  • Vaginal atrophy: Microscopically, the vaginal epithelium loses glycogen content and becomes thinner; supportive collagen and elastin fibers diminish, and mucosal blood flow decreases. Clinically, this manifests as vaginal dryness, decreased elasticity, and sometimes symptoms during intercourse or pelvic examinations. Vaginal pH typically increases toward neutral, facilitating shifts in the microbiome. (ACOG; NIH)
  • Long-term structural changes: With aging, labial tissues may atrophy and shift in appearance, vulvar skin may become pale and thin, and pubic hair patterns may change. These are normal aging phenomena but can be associated with discomfort or skin conditions (e.g., lichen sclerosus). The risk of vulvovaginal and urinary disorders increases with advancing age. (Mayo Clinic)

Microbiome and pH changes across life

  • Reproductive years: The vaginal microbiome is typically dominated by lactobacilli, which metabolize glycogen (derived from estrogen-stimulated epithelial cells) into lactic acid, maintaining an acidic environment hostile to many pathogens. (NIH)
  • Postmenopausal shift: As estrogen declines, epithelial glycogen decreases, lactobacillus populations fall, and vaginal pH rises. This ecological shift increases susceptibility to bacterial vaginosis and urinary tract infections in some women. Restoring local estrogen (topical therapies) can reverse many of these changes by thickening the epithelium and reestablishing a more lactobacillus-dominant microbiome in many cases. (Mayo Clinic; ACOG)

Common clinical problems across the lifespan

  • Vaginal infections: Bacterial vaginosis, vulvovaginal candidiasis (yeast), and trichomoniasis are common at various ages and present with differing types of discharge, odor, itching or irritation. Accurate diagnosis and appropriate antimicrobial or antifungal therapy are important. Avoidance of douching is recommended because it disrupts the normal flora and increases infection risk. (ACOG; Mayo Clinic)
  • Sexually transmitted infections (STIs): STIs can occur at any age of sexual activity. Screening, vaccination (e.g., HPV), partner management, and safe sexual practices reduce risks. Some STIs have long-term consequences if untreated, including pelvic inflammatory disease, infertility and increased cancer risks (e.g., persistent HPV infection). (ACOG; NIH)
  • Pelvic organ prolapse and incontinence: As described above, childbirth and aging increase risk. Conservative measures (pelvic floor rehabilitation, pessaries) and surgical options are available for symptomatic women. Early referral to a pelvic floor specialist is appropriate for moderate to severe symptoms. (Cleveland Clinic; ACOG)
  • Dermatologic conditions: Postmenopausal women have a higher incidence of dermatologic vulvar disorders such as lichen sclerosus, which can cause itching, skin thinning, and scarring. Any persistent vulvar skin changes or itching should prompt evaluation. (Mayo Clinic)
  • Malignancies and precancerous conditions: Risk of cervical cancer is highest in middle-aged women who have had persistent high-risk HPV infections; cervical screening programs (Pap tests and HPV testing) aim to detect precancerous lesions. Vulvar and vaginal cancers are less common but their incidence rises with age. Regular screening, awareness of abnormal bleeding or masses, and prompt evaluation are essential. (ACOG; NIH)

Treatment and prevention strategies

  • Routine gynecologic care: Regular well-woman visits, cervical cancer screening per guidelines, STI screening as indicated, and vaccination where appropriate are foundational to vulvovaginal health. (ACOG; NIH)
  • Hygiene and topical care: Gentle cleansing with water and mild soap, avoiding douching and scented products, wearing breathable cotton underwear, and avoiding prolonged wetness (i.e., wearing wet swimwear for long periods) help maintain a healthy environment. Overuse of antiseptic washes and fragranced products can disrupt the microbiome. (Mayo Clinic)
  • Lubricants and moisturizers: For symptomatic dryness, water-based lubricants provide short-term relief during intercourse or examinations. Vaginal moisturizers provide longer-acting hydration and may reduce day-to-day symptoms. Products designed for vaginal use without irritant additives are preferable. (ACOG; Mayo Clinic)
  • Local vaginal estrogen: For moderate to severe GSM or vaginal atrophy, low-dose local estrogen therapies (creams, tablets, rings) are effective in restoring mucosal thickness, improving lubrication and reducing urinary symptoms in many women. Local therapies deliver small amounts of hormone to the tissues with minimal systemic absorption for most patients but should be used under clinician guidance, especially in women with a history of estrogen-sensitive malignancies. (ACOG; Mayo Clinic; NIH)
  • Systemic hormone therapy: For women with vasomotor symptoms and other menopausal complaints, systemic hormone therapy (estrogen with or without progesterone) may be considered after individualized risk–benefit counseling. Systemic therapy can help vulvovaginal symptoms but is primarily indicated for systemic menopausal symptoms. Decisions about initiation and duration should follow current guidelines and involve shared decision-making. (ACOG; Mayo Clinic)
  • Non-hormonal prescription options: Ospemifene (a selective estrogen receptor modulator) is an oral prescription option for dyspareunia related to GSM in women who are not candidates for estrogen therapy. Vaginal DHEA (prasterone) is another prescription option in some settings. Discuss risks and benefits with a healthcare provider. (NIH; ACOG)
  • Pelvic floor rehabilitation: Supervised pelvic floor physical therapy is effective for urinary incontinence, pelvic pain syndromes, and some degrees of prolapse. Early referral is recommended for women with symptoms after childbirth or with progressive pelvic floor dysfunction. (Cleveland Clinic; ACOG)
  • Pessaries and surgery: For symptomatic pelvic organ prolapse, minimally invasive options include pessary devices that support the pelvic organs internally. When conservative options fail or are inappropriate, surgical repair may be considered; the approach depends on the type and severity of prolapse and patient preferences. (Cleveland Clinic; ACOG)
  • Caution regarding elective “cosmetic” vaginal procedures: Professional societies, including ACOG, caution against marketed “vaginal rejuvenation” or energy-based procedures that lack robust evidence for safety and efficacy and may have potential harms. Women should discuss the evidence, risks and alternatives with qualified clinicians and prioritize treatments supported by clinical data. (ACOG)

When to seek medical evaluation

Contact a healthcare provider for evaluation if any of the following occur:

  • New, persistent or foul-smelling vaginal discharge
  • Vaginal bleeding outside of expected menses (postmenopausal bleeding is an alarm symptom)
  • Persistent vulvar itching, pain, skin changes or lumps
  • Pain with intercourse that interferes with daily life
  • New or worsening urinary incontinence, urgency, or recurrent urinary tract infections
  • Prolapse symptoms (a bulge or pressure in the vagina)
  • Any concern about sexually transmitted infections or potential exposure

Early evaluation allows timely treatment and can prevent complications. (Mayo Clinic; ACOG)

Practical guidance for vulvovaginal health at every age

  • Maintain routine preventive care: Attend recommended well-woman visits and screening tests. Discuss contraception and STI prevention as needed. (ACOG)
  • Practice gentle hygiene: Avoid douching and scented products; use water and mild soap. Wear breathable fabrics. (Mayo Clinic)
  • For new symptoms, seek evaluation: Prompt assessment of abnormal bleeding, discharge, pain or skin changes improves diagnostic accuracy and outcomes. (Mayo Clinic)
  • For pelvic floor health: Consider pelvic floor strengthening exercises (guided by a specialist when indicated) especially after childbirth. Early physiotherapy referral often improves outcomes. (Cleveland Clinic)
  • For menopausal symptoms: Discuss non-hormonal and hormonal treatment options with a clinician experienced in menopause care, weighing individual risks, preferences and comorbidities. (ACOG; Mayo Clinic)

Summary

The vagina and surrounding pelvic tissues change across the lifespan in response to hormonal shifts, reproductive events and aging. In childhood and puberty, hormone-driven maturation establishes the adult vaginal environment. During the reproductive years, the vagina maintains a well-lubricated, lactobacillus-dominant milieu that protects against many infections. Childbirth and pelvic floor injuries can produce lasting anatomic and functional changes. Perimenopause and menopause bring estrogen deficiency that causes thinning of the tissues, changes in microbiome and symptoms that may impact quality of life. Many of these changes are normal and manageable; effective prevention and treatment options are available, including topical therapies, pelvic floor rehabilitation and lifestyle measures. Ongoing communication with a healthcare provider ensures individualized care and timely management when problems arise. (ACOG; NIH; Mayo Clinic; Cleveland Clinic)

References and resources (selected):

  • American College of Obstetricians and Gynecologists (ACOG) practice committee opinions and patient education materials on menopause, pelvic floor disorders, and vaginal cosmetic procedures. (ACOG)
  • National Institutes of Health (NIH) resources on reproductive health, the vaginal microbiome, and menopause research. (NIH/NICHD)
  • Mayo Clinic patient information pages on menopause, vaginal atrophy, and vaginal infections. (Mayo Clinic)
  • Cleveland Clinic resources on pelvic organ prolapse, pelvic floor dysfunction, and postpartum recovery. (Cleveland Clinic)

For more individualized recommendations, consult a gynecologist, primary care clinician, or a pelvic floor physiotherapist.